SKI Market

A+| A| A-|

Indian Indices

Sensex

74,563.92 -1,470.50
( -1.93%)

Global Indices

Nasdaq

46,702.98 -735.30
(-1.55%)

Dow Jones

6,694.68 -102.12
(-1.50%)

Hang Seng

53,838.16 -614.80
(-1.13%)

Nikkei 225

10,300.41 -53.36
(-0.52%)

Forex

USD-INR

91.92 0.02
(0.02%)

EUR-INR

106.58 -0.28
(-0.27%)

GBP-INR

123.39 -0.12
(-0.10%)

JPY-INR

0.58 0.00
(-0.46%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Coral Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524506

INE683E01017

596.8851541

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

11.17

159.58

EPS(TTM)

Face Value()

Div & Yield %

40.01

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	115.01	83.66	78.12	75.61	96.57	70.58
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	115.01	83.66	78.12	75.61	96.57	70.58
Other Income	9.11	6.63	6.93	5.77	3.79	5.89
Stock Adjustments	-3.32	3.13	-3.64	-0.71	0.05	2.94
Total Income	120.80	93.42	81.41	80.67	100.41	79.41
EXPENDITURE :
Raw Materials	49.70	40.38	42.11	39.01	50.11	42.97
Power & Fuel Cost	3.16	3.05	3.10	2.55	2.05	1.82
Employee Cost	14.74	11.20	11.13	11.23	10.18	9.70
Other Manufacturing Expenses	4.22	3.96	4.55	4.01	5.81	4.64
Selling & Administrative Expenses	8.17	8.39	9.55	9.61	9.32	6.45
Miscellaneous Expenses	6.24	3.74	0.23	0.28	3.29	2.52
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	86.22	70.72	70.68	66.69	80.76	68.10
Operating Profit	34.58	22.71	10.75	13.99	19.64	11.31
Interest	0.10	0.00	0.34	0.14	0.04	0.19
Gross Profit	34.48	22.71	10.41	13.85	19.60	11.12
Depreciation	2.01	1.98	2.18	1.99	1.98	2.01
Profit Before Tax	32.47	20.73	8.23	11.86	17.62	9.11
Tax	8.33	4.91	1.82	2.75	4.50	2.50
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.02	0.03	-0.04	0.06	-0.44	-0.51
Reported Net Profit	24.16	15.79	6.45	9.05	13.55	7.13
Extraordinary Items	-0.57	-0.12	0.03	0.73	0.01	0.00
Adjusted Net Profit	24.73	15.91	6.42	8.32	13.54	7.13
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	-4.37
P & L Balance brought forward	147.46	131.67	125.23	116.18	102.63	105.99
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.71	0.00	0.00	0.00	0.00	0.86
P & L Balance carried down	170.90	147.46	131.67	125.23	116.18	107.89
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	67.61	44.19	18.04	25.32	37.94	19.96
Earnings Per Share(Adj)-Unit Curr	67.61	44.19	18.04	25.32	37.94	19.96
Book Value-Unit Curr	563.19	496.83	433.29	436.81	382.48	323.77
Book Value(Adj)-Unit Curr	563.19	496.83	433.29	436.81	382.48	323.77

74,563.92 -1,470.50 ( -1.93%)

46,702.98 -735.30 (-1.55%)

6,694.68 -102.12 (-1.50%)

53,838.16 -614.80 (-1.13%)

10,300.41 -53.36 (-0.52%)

91.92 0.02 (0.02%)

106.58 -0.28 (-0.27%)

123.39 -0.12 (-0.10%)

0.58 0.00 (-0.46%)